In this guest article, Carla Stratfold, CEO at OnRequest Images, presents several key learnings and best practices that pharmas can follow when building brand and consumer loyalty.
At a recent ExL Pharma conference industry leaders from pharma and the vendor community reviewed the impact on
The recent FDA Draft Guidance for Industry, Presenting Risk Information in Prescription Drug and Medical Device Promotion guidance focuses almost exclusively on print and broadcast promotional ads. It is possible, however, to apply some of FDA's
Welcome to the NOV/DEC 2009 issue of Pharma Marketing News.
Welcome to the March 2009 issue of Pharma Marketing News.
Pharma Marketing News surveyed readers to determine if medical journal articles sponsored and ghostwritten by drug companies are a legitimate part of marketing to physicians and to get opinions on various other issues raised in the press about ghostwriting.
Welcome to the August 2009 issue of Pharma Marketing News.
Welcome to the October 2009 issue of Pharma Marketing News.
Pharmaceutical Market Access 2010: Strategic Developments Impacting the US, EU, and Emerging Markets
Future revenue growth in the US and EU will be limited as the EU wrestles with cost effectiveness and the US debates healthcare reforms. Meanwhile, pharma and biotech companies are looking to emerging market opportunities in Brazil, Russia, India, and China (i.e., BRIC) to drive future business. What does this all mean for patients, physicians, payers, and pharmaceutical/biotech manufacturers? This article addresses that question.
Pharma Marketing Network's ePharma Pioneer Club is an EXCLUSIVE, members-only Facebook Group through which pharmaceutical eMarketing experts 'meet' to discuss and exchange views on how to advance the use of the Internet and other technologies in pharmaceutical marketing, sales, and communications.